The Question Is Whether To Buy Or Not To Buy Arcutis Biotherapeutics Inc (NASDAQ: ARQT)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Arcutis Biotherapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Arcutis Biotherapeutics Inc is $1.71B. A total of 1.81 million shares were traded on the day, compared to an average of 2.23M shares.

In the most recent transaction, Burnett Patrick sold 2,819 shares of ARQT for 13.03 per share on Mar 03 ’25. After the transaction, the insider now owns 167,043 company shares. In a previous transaction on Mar 04 ’25, Burnett Patrick sold 954 shares at 13.28 per share. ARQT shares that the insider owns now total 166,089.

Among the insiders who sold shares, Watanabe Todd Franklin disposed of 20,880 shares on Mar 03 ’25 at a per-share price of $13.03. This resulted in the insider holding 934,249 shares of ARQT after the transaction. In another insider transaction, Watanabe Todd Franklin sold 4,135 shares at $13.28 per share on Mar 04 ’25. Company shares held by the insider now total 930,114.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, ARQT has a high of $16.20 and a low of $6.99.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. ARQT’s latest balance sheet shows that the firm has $387.06M in Cash & Short Term Investments as of fiscal 2021. There were $77.56M in debt and $33.33M in liabilities at the time. Its Book Value Per Share was $1.34, while its Total Shareholder’s Equity was $297.68M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARQT is Buy with a score of 4.63.

Most Popular

Related Posts